A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).

Mater Researcher Dr Jake Gratten has received more than $98,000 in funding to progress research into anxiety and gastrointestinal disorders in autistic children.

Following an international search, Professor Maher Gandhi has been appointed Director of Clinical Research at Mater Research.

Mater researchers received two prestigious awards at this year’s Women in Technology (WiT) awards ceremony held at the Royal International Convention Centre last week (Friday 14 September).

Mater Research’s Cancer Immunotherapies Research Group have received prestigious travel awards to attend international conferences

Dr Jake Gratten has joined Mater Research to head up the Cognitive Health Genomics group.

Dr Shelley Wilkinson is a Senior Research Dietitian at the Mater Mothers' Hospital who is undertaking research to help women have healthier pregnancies.

Prof John Hooper & his team are working towards improving the diagnosis & treatment of ovarian cancer by developing a unique PET imaging agent that shows the exact location and extent of the tumour.

The inaugural Brisbane Calcium Symposium was held on 1 August.

Four researchers from Mater Research have been selected as Career Track Fellows for 2018.

Mater Research is planning the largest group cohort study in the state since the 1980s, aiming to follow 10 000 Queensland families over three decades.

Dying to Know Day, held on 8 August, aims to encourage all Australians to talk about death by promoting conversations and community actions around death, dying and bereavement.